Simple Peptide scores well here with phone, email, and social media channels staffed by responsive agents
Tranexamic acid has the best evidence for treating melasma, however it is a thrombophilic drug and thus should be prescribed in select patients
SURMOUNT-5 Head-to-Head In 2025, Eli Lilly published the SURMOUNT-5 trial directly comparing tirzepatide (15 mg) and semaglutide (2.4 mg) in adults with obesity over 72 weeks
In this scenario, compounding pharmacies, which are overseen at the state and federal level, would obtain active ingredients from FDA-registered manufacturers
This protocol works because it attacks GLP-1 constipation from every angle simultaneously
In these trials, all participants received instruction for an approximately 500 kcal/day deficit and physical activity counseling